CONSOLIDATED AND COMBINED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net (loss) earnings	$ (9,114)	$ 25,887
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Stock-based compensation expense	24,906	4,461
Amortization of intangibles	16,306	1,367
Bad debt expense	9,434	5,899
Depreciation	6,184	2,996
Deferred income taxes	(4,178)	2,329
Other adjustments, net	(63)	55
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable	(17,650)	(14,457)
Other assets	(13,748)	(10,721)
Accounts payable and other liabilities	(5,329)	14,594
Income taxes payable and receivable	162	(28,509)
Deferred revenue	4,191	4,199
Net cash provided by operating activities	11,101	8,100
Cash flows from investing activities:
Acquisitions, net of cash acquired		(52,365)
Capital expenditures	(8,886)	(3,747)
Proceeds from sale of fixed assets	10,410
Net cash provided by (used in) investing activities	1,524	(56,112)
Cash flows from financing activities:
Principal payment on term loan	(3,438)	0
Proceeds from issuance of related party debt	0	51,855
Principal payments on related party debt	(618)	(2,838)
Proceeds from the exercise of stock options	1,752	0
Withholding taxes paid on behalf of employees on net settled stock-based awards	(2,925)	0
Transfers from IAC/InterActiveCorp for periods prior to the Combination	0	6,193
Purchase of noncontrolling interests	(234)	(12,259)
Other, net	39
Net cash (used in) provided by financing activities	(5,424)	42,951
Total cash provided (used)	7,201	(5,061)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	22	659
Net increase (decrease) in cash, cash equivalents, and restricted cash	7,223	(4,402)
Cash, cash equivalents, and restricted cash at beginning of period	221,521	46,925
Cash, cash equivalents, and restricted cash at end of period	$ 228,744	$ 42,523